title: Electronic cigarette use and harm reversal: emerging evidence in the lung.
abstract: Electronic cigarettes (ECs) have been rapidly gaining ground on conventional cigarettes due to their efficiency in ceasing or reducing tobacco consumption, competitive prices, and the perception of them being a much less harmful smoking alternative. Direct confirmation that long-term EC use leads to reductions in smoking-related diseases is not available and it will take a few decades before the tobacco harm reduction potential of this products is firmly established. Nonetheless, it is feasible to detect early changes in airway function and respiratory symptoms in smokers switching to e-vapor. Acute investigations do not appear to support negative respiratory health outcomes in EC users and initial findings from long-term studies are supportive of a beneficial effect of EC use in relation to respiratory outcomes. The emerging evidence that EC use can reverse harm from tobacco smoking should be taken into consideration by regulatory authorities seeking to adopt proportional measures for the e-vapor category.
authors: Riccardo
authors: R
authors: Polosa
mesh_terms: D066300:Electronic Nicotine Delivery Systems; D040261:Harm Reduction; D006801:Humans; D008171:Lung Diseases / Q000517:prevention & control*; D014029:Tobacco Use Disorder / Q000517:prevention & control*